alreadi
known
topic
fraction
exhal
nitric
oxid
feno
tool
use
diagnos
asthma
predict
posit
respons
inhal
steroid
therapi
help
measur
adher
inhal
steroid
therapi
patient
chronic
asthma
unfortun
util
manag
acut
asthma
wide
studi
articl
add
knowledg
studi
found
children
acut
asthma
exacerb
feno
level
elev
compar
baselin
level
addit
feno
level
rise
greater
extent
children
viralinduc
asthma
exacerb
suggest
eosinophil
inflamm
play
role
noneviralinduc
asthma
exacerb
last
prednison
effect
reduc
feno
level
baselin
state
biggest
reduct
seen
viral
infect
studi
impact
current
manag
guidelin
studi
suggest
feno
use
marker
inflamm
acut
asthma
exacerb
prednison
therapi
improv
lung
function
normal
feno
level
children
acut
asthma
regardless
underli
caus
exacerb
background
fraction
exhal
nitric
oxid
feno
level
use
aid
diagnosi
manag
chronic
asthma
role
acut
asthma
remain
studi
object
determin
whether
feno
level
elev
children
asthma
exacerb
compar
baselin
whether
differ
feno
level
base
pcr
effect
viral
infect
exhal
nitric
oxid
children
acut
asthma
exacerb
jonathan
malka
md
b
ronina
covar
md
c
anna
faino
ms
e
jennif
fish
cpnp
f
paig
picker
bs
g
preveen
ramamoorthi
md
g
melani
gleason
pac
b
h
joseph
spahn
md
b
h
aventura
fla
denver
aurora
colo
alreadi
known
topic
fraction
exhal
nitric
oxid
feno
tool
use
diagnos
asthma
predict
posit
respons
inhal
steroid
therapi
help
measur
adher
inhal
steroid
therapi
patient
chronic
asthma
unfortun
util
manag
acut
asthma
wide
studi
articl
add
knowledg
studi
found
children
acut
asthma
exacerb
feno
level
elev
compar
baselin
level
addit
feno
level
rise
greater
extent
children
viralinduc
asthma
exacerb
suggest
eosinophil
inflamm
play
role
noneviralinduc
asthma
exacerb
last
prednison
effect
reduc
feno
level
baselin
state
biggest
reduct
seen
viral
infect
studi
impact
current
manag
guidelin
studi
suggest
feno
use
marker
inflamm
acut
asthma
exacerb
prednison
therapi
improv
lung
function
normal
feno
level
children
acut
asthma
regardless
underli
caus
exacerb
background
fraction
exhal
nitric
oxid
feno
level
use
aid
diagnosi
manag
chronic
asthma
role
acut
asthma
remain
studi
object
determin
whether
feno
level
elev
children
asthma
exacerb
compar
baselin
whether
differ
feno
level
base
pcr
posit
respiratori
viru
isol
pcr
analysi
versu
pcr
neg
l
respiratori
viru
isol
pcr
analysi
statu
method
children
previou
feno
level
measur
stabl
present
urgent
care
facil
asthma
exacerb
enrol
feno
level
spirometri
nasal
swab
viral
pcr
obtain
time
exacerb
follow
cours
prednison
data
avail
children
linear
mix
model
use
regress
outcom
interest
fev
fev
forc
vital
capac
forc
expiratori
flow
forc
vital
capac
natur
log
feno
detect
viru
yesno
visit
baselin
exacerb
followup
interact
detect
viru
visit
result
compar
baselin
higher
feno
valu
lower
lung
function
found
time
exacerb
respiratori
viru
detect
exacerb
interact
pcr
pcr
l
group
visit
log
feno
margin
signific
p
differ
log
feno
pcr
pcr
l
group
baselin
higher
log
feno
found
pcr
l
group
time
exacerb
follow
prednison
p
respect
conclus
higher
feno
concentr
pcr
l
exacerb
suggest
eosinophil
predomin
nonvir
compar
viral
exacerb
american
academi
allergi
asthma
immunolog
j
allergi
clin
immunol
pract
key
word
childhood
asthma
fraction
exhal
nitric
oxid
feno
asthma
exacerb
abbrevi
use
edemerg
depart
fef
forc
expiratori
flow
forc
vital
capac
fenofract
exhal
nitric
oxid
fvcforc
vital
capac
gcglucocorticoid
pcr
respiratori
viru
isol
pcr
analysi
pcr
respiratori
viru
isol
pcr
analysi
asthma
chronic
inflammatori
disord
commonli
associ
eosinophil
infiltr
airway
releas
sever
inflammatori
mediat
although
phenotyp
asthma
describ
neutrophil
paucigraniolocyt
fraction
exhal
nitric
oxid
feno
accept
noninvas
measur
airway
inflamm
use
diagnosi
manag
asthma
studi
shown
feno
effect
betaagonist
revers
methacholin
respons
diagnos
asthma
children
adult
feno
level
posit
correl
bronchial
wall
inflamm
inducedsputum
eosinophilia
airway
hyperrespons
increas
feno
associ
deterior
asthma
control
poor
inhal
glucocorticoid
gc
adher
wherea
feno
level
fall
dosedepend
manner
inhal
gc
treatment
despit
enhanc
knowledg
feno
chronic
asthma
littl
known
regard
role
acut
asthma
recent
publish
studi
feno
found
use
acut
asthma
could
measur
children
present
emerg
depart
ed
acut
asthma
second
studi
feno
fail
distinguish
children
requir
hospit
discharg
home
neither
studi
feno
level
avail
baselin
attempt
made
determin
role
viral
infect
play
feno
level
aim
studi
determin
whether
feno
level
elev
acut
asthma
exacerb
compar
baselin
children
persist
asthma
determin
influenc
viral
infect
feno
level
children
present
acut
asthma
exacerb
requir
prednison
therapi
prospect
crosssect
studi
inform
consent
obtain
parent
guardian
assent
obtain
child
appropri
studi
review
approv
nation
jewish
health
institut
review
board
studi
perform
nation
jewish
health
urgent
care
clinic
june
may
total
particip
age
year
enrol
chose
age
group
children
age
perform
adequ
spirometri
exhal
nitric
oxid
measur
patient
present
urgent
care
clinic
nation
jewish
health
acut
asthma
exacerb
undergon
spirometri
feno
measur
within
last
month
clinic
stabl
visit
approach
particip
studi
figur
patient
could
perform
either
spirometri
feno
measur
time
exacerb
inelig
patient
treat
prednison
within
week
urgent
care
visit
children
histori
lung
diseas
asthma
patient
histori
vocal
cord
dysfunct
also
exclud
particip
studi
consent
assent
obtain
particip
complet
clinic
questionnair
spirometri
feno
measur
nasal
swab
obtain
viral
pcr
visit
urgent
care
physician
independ
direct
treatment
determin
particip
disposit
treat
physician
studi
investig
decis
treat
prednison
discret
treat
physician
use
treatment
algorithm
base
nation
asthma
educ
prevent
program
guidelin
particip
discharg
home
instruct
continu
usual
control
medic
take
albuterol
frequenc
direct
urgent
care
physician
complet
cours
oral
prednison
mgkgd
maximum
daili
dose
mg
discharg
particip
also
schedul
followup
week
later
visit
followup
visit
particip
underw
spirometri
feno
level
measur
particip
underw
spirometri
least
accept
maneuv
three
highest
forc
vital
capac
fvc
fev
valu
record
accord
american
thorac
societi
guidelin
use
jaeger
masterscreen
pneumo
run
jlab
softwar
erich
jaeger
inc
wurzburg
germani
data
fev
fvc
forc
expiratori
flow
forc
vital
capac
fef
express
predict
use
nhane
iii
refer
valu
feno
level
obtain
spirometri
administr
shortact
betaagonist
therapi
feno
level
measur
use
onlin
techniqu
recommend
american
thorac
societi
niox
mino
system
aerocrin
ab
stockholm
sweden
techniqu
use
resist
devic
provid
constant
low
expiratori
flow
rate
vellum
closur
combin
vellum
closur
low
flow
rate
ensur
accur
measur
pulmonaryderiv
exhal
level
exclud
contamin
nasal
particip
exhal
residu
volum
insert
mouthpiec
inhal
total
lung
capac
exhal
second
steadi
rate
ml
visual
incent
provid
feedback
flow
rate
complianc
end
point
measur
occur
plateau
second
observ
measur
obtain
repeat
feno
obtain
niox
mino
high
comparison
pcr
respiratori
viru
isol
pcr
analysi
pcr
respiratori
viru
isol
pcr
analysi
group
baselin
time
exacerb
evalu
use
independ
sampl
test
normal
distribut
continu
variabl
wilcoxon
ranksum
test
variabl
normal
distribut
use
either
c
test
fisher
exact
test
small
expect
number
categor
variabl
linear
mix
model
use
regress
outcom
interest
fev
fev
fvc
fef
natur
log
feno
detect
viru
yesno
visit
baselin
exacerb
followup
interact
detect
viru
visit
interact
main
predictor
interest
model
kept
model
even
statist
signific
allow
model
flexibl
covari
interest
adjust
model
season
winter
spring
summer
fall
inhal
gc
therapi
yesno
also
sex
weight
height
race
hispan
african
american
caucasian
adjust
feno
model
backward
select
use
pvalu
cutoff
use
remov
insignific
covari
final
adjust
model
includ
season
covari
addit
adjust
feno
model
contain
age
race
hispan
african
american
caucasian
covari
model
contain
random
intercept
account
repeat
measur
unequ
time
visit
across
subject
spatial
power
covari
structur
base
day
exacerb
use
analys
done
sa
version
plot
gener
r
version
june
may
particip
enrol
tabl
five
subject
return
visit
includ
analysi
mean
age
ae
year
male
atop
presenc
posit
skin
test
result
aeroallergen
obes
fortythre
percent
enrol
children
caucasian
hispan
african
american
fourteen
percent
carri
diagnosi
mildpersist
moderatepersist
severepersist
asthma
seventyf
percent
subject
inhal
gc
therapi
inhal
gc
monotherapi
combin
inhal
gclongact
betaagonist
therapi
report
ed
visit
acut
asthma
past
year
requir
system
steroid
last
month
histori
hospit
admiss
acut
asthma
review
medic
use
baselin
visit
compar
time
exacerb
visit
found
signific
differ
percentag
studi
particip
inhal
gc
therapi
alon
combin
longact
betaagonist
signific
differ
found
inhal
gc
dose
visit
compar
visit
addit
feno
level
lung
function
normal
rang
visit
geometr
mean
feno
level
ppb
four
subject
miss
record
calendar
date
visit
exclud
mix
model
total
subject
fev
fev
fvc
fef
model
addit
subject
miss
baselin
followup
feno
measur
subject
miss
race
inform
total
subject
feno
model
visit
subject
median
daytim
symptom
dwk
nighttim
symptom
time
month
requir
rescu
albuterol
durat
compar
baselin
signific
increas
log
exhal
decreas
lung
function
fev
predict
fev
fvc
fef
predict
note
time
exacerb
p
valu
tabl
ii
iii
visit
signific
decreas
log
exhal
improv
lung
function
paramet
fev
predict
fev
fvc
fef
predict
respect
p
found
time
exacerb
measur
initi
prednison
tabl
iii
differ
log
feno
p
fev
predict
p
fev
fvc
p
fef
predict
p
initi
prednison
treatment
baselin
measur
fiftysix
percent
children
evid
pcr
exacerb
respiratori
virus
identifi
pcr
differ
patient
demograph
characterist
note
baselin
children
pcr
versu
pcr
asthma
exacerb
tabl
commonli
identifi
viru
rhinoviru
occur
particip
follow
corona
viru
influenza
metapneumoviru
parainfluenza
children
posit
viral
pcr
viru
identifi
time
exacerb
use
unadjust
adjust
model
chang
follow
outcom
log
feno
fev
fev
fvc
fef
evalu
pcr
pcr
group
unadjust
log
feno
model
interact
pcr
pcr
group
visit
margin
signific
p
figur
trend
also
found
use
adjust
analysi
p
figur
b
unadjust
adjust
model
differ
log
feno
exacerb
group
pcr
viral
detect
baselin
steadi
state
higher
log
feno
found
pcr
pcr
children
time
exacerb
initi
prednison
cours
p
respect
adjust
analysi
differ
found
pcr
pcr
group
measur
lung
function
studi
across
visit
studi
children
asthma
sought
determin
whether
feno
level
elev
acut
asthma
exacerb
also
sought
determin
role
pcr
exacerb
feno
level
last
sought
determin
effect
prednison
feno
level
whether
differ
respons
prednison
base
whether
exacerb
pcr
found
feno
level
rise
significantli
acut
exacerb
asthma
biggest
increas
note
pcr
associ
exacerb
follow
short
cours
prednison
therapi
feno
level
fell
near
baselin
level
greatest
reduct
pcr
exacerb
studi
sought
evalu
feno
level
acut
asthma
lanz
et
al
found
feno
level
elev
children
acut
asthma
compar
level
atop
children
without
asthma
normal
control
children
follow
cours
prednison
feno
level
fell
control
without
asthma
limit
studi
includ
small
number
children
studi
lack
preexacerb
feno
level
kwok
et
al
use
tidal
breath
techniqu
assess
feno
level
children
present
ed
asthma
exacerb
found
children
abl
success
perform
maneuv
abl
provid
adequ
sampl
differ
found
feno
level
among
mild
moder
sever
exacerb
studi
limit
techniqu
use
measur
feno
level
lack
baselin
feno
level
nelson
et
al
sought
determin
whether
feno
level
time
ed
visit
could
predict
children
requir
hospit
acut
asthma
found
feno
level
could
distinguish
children
requir
hospit
discharg
home
studi
limit
small
number
children
requir
hospit
compar
discharg
home
studi
novel
collect
baselin
exacerb
postprednison
feno
level
addit
attempt
determin
etiolog
acut
asthma
exacerb
found
feno
level
highest
children
acut
asthma
exacerb
associ
viral
infect
pcr
group
children
exacerb
like
allergendriven
situat
offend
allergen
trigger
immedi
latephas
allerg
respons
lead
bronchoconstrict
airway
edema
consequ
figur
exhal
nitric
oxid
level
baselin
exacerb
follow
cours
prednison
unadjust
model
plot
valu
mean
estim
ae
standard
error
unadjust
linear
mix
model
black
circl
dot
line
correspond
pcr
group
gray
squar
solid
line
correspond
pcr
group
b
chang
exhal
nitric
oxid
level
baselin
exacerb
follow
cours
prednison
adjust
model
plot
valu
mean
estim
ae
standard
error
adjust
linear
mix
model
model
adjust
season
fall
feno
model
also
adjust
age
race
plot
mean
estim
feno
correspond
white
subject
mean
age
year
black
circl
dot
line
correspond
pcr
group
gray
squar
solid
line
correspond
pcr
group
ppb
part
per
billion
preform
mediat
inflamm
influx
eosinophil
feno
level
serv
surrog
eosinophil
inflamm
elev
feno
level
like
repres
influx
eosinophil
eosinophilderiv
airway
epitheli
damag
feno
level
also
increas
albeit
lesser
extent
pcr
driven
exacerb
pcr
exacerb
asthma
increas
come
larg
children
infect
rhinoviru
viralinduc
asthma
exacerb
often
associ
influx
neutrophil
airway
adult
asthma
sputum
induct
perform
time
acut
exacerb
neutrophil
inflamm
note
case
may
come
much
surpris
acut
asthma
exacerb
caus
respiratori
virus
past
studi
adult
asthma
demonstr
neutrophildriven
inflamm
associ
elev
feno
level
mechan
viral
infect
contribut
chang
airway
inflamm
alter
physiolog
result
asthma
exacerb
remain
incomplet
understood
messag
et
al
address
issu
inocul
asthma
healthi
control
human
rhinoviru
group
develop
respiratori
symptom
asthma
lung
function
impair
heighten
bronchial
respons
develop
eosinophil
inflamm
unlik
respiratori
syncyti
viru
influenza
viru
rhinoviru
uniqu
infect
asthma
result
increas
feno
level
way
increas
induc
nitric
oxid
synthas
express
airway
epitheli
cell
inde
children
viralassoci
exacerb
caus
rhinoviru
exclud
respiratori
virus
feno
level
elev
viral
infect
allerg
inflamm
damag
airway
epithelium
result
asthma
worsen
viralinduc
damag
airway
epithelium
lead
enhanc
absorpt
allergen
result
worsen
airway
inflamm
likewis
damag
airway
epithelium
allerg
inflamm
may
promot
viral
replic
sever
clinic
ill
thu
children
pcr
asthma
exacerb
like
mixtur
eosinophil
neutrophil
inflamm
result
moder
elev
feno
level
note
contrast
inflamm
underli
pcr
exacerb
like
pure
eosinophildriven
process
result
feno
level
would
expect
higher
studi
number
limit
first
methodolog
standpoint
would
prefer
perform
feno
measur
spirometri
spirometri
result
transient
reduct
feno
level
past
studi
shown
reduct
modest
ppb
unlik
significantli
alter
result
second
inquir
whether
patient
recent
ingest
food
contain
high
level
nitrat
whether
expos
household
cigarett
smoke
current
smoke
cigarett
ingest
food
contain
high
level
nitrat
caus
feno
level
elev
hour
current
cigarett
smoke
reduc
feno
level
addit
report
fev
fvc
ratio
percentag
oppos
fev
fvc
percent
predict
ratio
vari
age
sex
use
percentag
miss
inform
give
fals
sens
abnorm
anoth
limit
unabl
identifi
trigger
agent
involv
acut
exacerb
pcr
group
possibl
subject
react
inhal
season
allergen
newli
acquir
perenni
allergen
cat
dog
dander
altern
patient
may
fals
neg
pcr
result
last
although
specul
pcr
exacerb
like
eosinophil
driven
perform
sputum
induct
collect
peripher
blood
assess
eosinophilia
conclus
feno
level
elev
acut
childhood
asthma
higher
level
seen
children
pcr
exacerb
short
cours
prednison
result
signific
reduct
feno
level
futur
studi
need
better
understand
underli
pathophysiolog
differ
pcr
pcr
asthma
exacerb
potenti
import
therapi
may
alter
basi
underli
inflammatori
process
provid
optim
therapi
time
exacerb
attenu
airway
remodel
loss
lung
function
result
exacerb
may
achiev
